Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| May 25, 2017 | SVP/GM, Global Vascular | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| Jan 13, 2017 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 14,000 | -- | -- | |
| Aug 31, 2016 | Director | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 12,000 | -- | -- | |
| Aug 31, 2016 | Director | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 12,000 | -- | -- | |
| Jul 15, 2016 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 12,000 | -- | -- | |
| Jul 15, 2016 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 12,000 | -- | -- | |
| Jul 13, 2016 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 12,000 | -- | -- | |
| Jul 11, 2016 | SVP and General Counsel | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,151 | -- | -- | |
| Aug 05, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | -- | -- | |
| Aug 05, 2015 | VP - Global Franchise | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 14,100 | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.